To determine whether AURKA knockdown had an effect on chemosensitivity, a cytotoxicity assay was performed to measure IC50 values of paclitaxel, adriamycin, and cisplatin, which are widely used in gynecological cancer chemotherapy, before and after AURKA knockdown in HEC-1B cells. This evidence concerns the gene AURKA and female reproductive organ cancer.